Tarek El-Metwally | Non-Communicable Diseases | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Tarek El-Metwally
Affiliation Al Jouf University
Country Saudi Arabia
Scopus ID 6507910852
Documents 45
Citations 847
h-index 16
Subject Area Non-Communicable Diseases
Event Global Diseases Research Awards
ORCID 0000-0001-9040-6642

Tarek El-Metwally is a researcher affiliated with Al Jouf University, Saudi Arabia, whose scholarly profile is associated with the field of non-communicable diseases. His indexed research record comprises 45 documents, 847 citations, and an h-index of 16, according to the supplied Scopus profile information. [1]

Abstract

Tarek El-Metwally is an academic researcher affiliated with Al Jouf University in Saudi Arabia and associated with the research area of non-communicable diseases. The supplied bibliographic profile records 45 indexed documents, 847 citations, and an h-index of 16. These indicators provide a quantitative overview of scholarly productivity and citation-based research influence. His profile is presented in connection with the Innovative Research Award under the Global Diseases Research Awards. The recognition framework highlights research activity relevant to global disease challenges while providing structured information about institutional affiliation, publication activity, scholarly visibility, and researcher identification through Scopus and ORCID. The profile does not independently establish the quality or originality of individual studies, but summarizes supplied bibliometric information for academic recognition and reference.[1]

Keywords

Innovative Research Award, Tarek El-Metwally, Al Jouf University, Saudi Arabia, non-communicable diseases, disease research, biomedical research, research impact, Scopus, ORCID, scholarly publications, research recognition, Global Diseases Research Awards.[1]

Introduction

Non-communicable diseases represent a major area of global health research and include conditions requiring sustained investigation across epidemiology, prevention, diagnosis, treatment, and health systems. Research in this field increasingly depends on multidisciplinary evidence and internationally visible scholarly communication. The present profile situates Tarek El-Metwally within this broader research context.[1]

Research Profile

The supplied research profile identifies Tarek El-Metwally with Al Jouf University in Saudi Arabia and assigns Scopus Author ID 6507910852. The record contains 45 documents, 847 citations, and an h-index of 16. These bibliometric measures are commonly used to describe publication output and citation visibility within indexed scholarly literature. [4]

Research Contributions

The available profile information supports an assessment of sustained scholarly participation in non-communicable disease research. A record of 45 documents indicates continuing publication activity, while 847 citations demonstrate that the indexed publications have received measurable scholarly attention. Interpretation of individual contributions requires examination of the underlying publications and their research methodologies..[3]

Publications

The Scopus profile supplied for Tarek El-Metwally records 45 documents associated with the researcher identifier 6507910852. These documents form the bibliographic basis for the reported citation and h-index indicators. A complete publication-level assessment would require reviewing individual article titles, journals, publication years, co-authorship patterns, subject classifications, and citation records. [2]

Research Impact

The reported 847 citations and h-index of 16 provide quantitative indicators of the visibility of the researcher’s indexed scholarly output. Citation measures should be interpreted within disciplinary and career-stage contexts because citation practices vary across fields. They are useful descriptive indicators, but they should not be considered a complete measure of research quality or societal impact. [1]

Award Suitability

The supplied profile is presented for consideration under the Innovative Research Award associated with the Global Diseases Research Awards. Its subject alignment with non-communicable diseases and the reported scholarly indicators provide relevant contextual information for an academic recognition profile. Final award assessment should remain dependent on the applicable nomination, review, and judging criteria.[2]

Conclusion

Tarek El-Metwally’s supplied academic profile documents research activity associated with Al Jouf University and non-communicable diseases. The reported 45 documents, 847 citations, and h-index of 16 provide measurable indicators of indexed scholarly activity. The Innovative Research Award profile summarizes these indicators within the Global Diseases Research Awards framework..[5]

References

  1. Elsevier. (n.d.). Scopus author details: Tarek El-Metwally, Author ID 6507910852. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507910852
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Othman, E. E. D. R., Hornung, D., Salem, H. T., Khalifa, E. A., El-Metwally, T. H., & Al-Hendy, A. (2008). Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 137(2), 240–246.
    https://doi.org/10.1016/j.ejogrb.2007.05.001
  4. Ding, X.-Z., Kuszynski, C. A., El-Metwally, T. H., & Adrian, T. E. (1999). Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochemical and Biophysical Research Communications, 266(2), 392–399.
    https://doi.org/10.1006/bbrc.1999.1824
  5. Ragab, S. M. M., Abd Elghaffar, S. K., El-Metwally, T. H., Badr, G., Mahmoud, M. H., & Omar, H. M. (2015). Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: The ameliorative role of three natural compounds. Lipids in Health and Disease, 14, 83. https://doi.org/10.1186/s12944-015-0087-1 

Roberto Berni Canani | Non-Communicable Diseases | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Roberto Berni Canani
Università degli Studi di Napoli Federico II, Italy

                 Roberto Berni Canani
Affiliation Università degli Studi di Napoli Federico II
Country Italy
Scopus ID 57008139600
Documents 330
Citations 26,391
h-index 72
Subject Area Non-Communicable Diseases
Event Global Diseases Research Awards
ORCID 0000-0002-5169-9574

Roberto Berni Canani is a researcher affiliated with the Università degli Studi di Napoli Federico II, Italy, whose academic profile encompasses pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research integrates clinical and translational perspectives, contributing to scientific understanding of gastrointestinal health, nutrition-related mechanisms, immune responses, and disease prevention within biomedical research. [1]

Abstract

Roberto Berni Canani is an Italian researcher affiliated with the Università degli Studi di Napoli Federico II whose academic activities encompass pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research profile reflects multidisciplinary investigation connecting clinical medicine with nutritional, immunological, gastrointestinal, and translational research. The supplied Scopus information records 330 documents, 26,391 citations, and an h-index of 72. His scientific work addresses relationships between nutrition, intestinal biology, immune responses, allergic conditions, and disease mechanisms, contributing to evidence-based understanding of health and disease. These research areas provide a relevant academic foundation for consideration for the Research Excellence Award within the Global Diseases Research Awards. [2]

Keywords

Roberto Berni Canani, Research Excellence Award, pediatric medicine, gastroenterology, nutrition, allergy, microbiome, food-induced diseases, gastrointestinal health, immunology, translational research, non-communicable diseases, biomedical research, Università degli Studi di Napoli Federico II, Italy. [2]

Introduction

Research into nutrition, gastrointestinal health, allergy, and immune-mediated disease has become increasingly interdisciplinary, combining clinical investigation with biological and nutritional sciences. Roberto Berni Canani’s academic profile is positioned within these interconnected fields, with research addressing pediatric health and disease mechanisms. His institutional affiliation provides an academic setting for multidisciplinary scientific investigation and collaboration.[1]

Research Profile

Roberto Berni Canani is affiliated with the Università degli Studi di Napoli Federico II and has an academic research profile indexed through Scopus. The supplied record identifies 330 documents, 26,391 citations, and an h-index of 72. His research interests encompass nutrition, pediatric gastroenterology, allergy, microbiome science, and food-related disease research.[1]

Research Contributions

Berni Canani’s research contributions include investigation of relationships among nutrition, gastrointestinal function, immune responses, and allergic disease. These areas are relevant to understanding how dietary exposures and biological processes interact in childhood health. His work illustrates an interdisciplinary research approach combining clinical questions with nutritional, immunological, and translational perspectives.[2]

Publications

The researcher’s publication record covers scientific topics associated with pediatric allergy, nutrition, gastrointestinal disorders, and related biomedical disciplines. His scholarly output contributes to peer-reviewed scientific communication and supports continuing investigation of mechanisms underlying disease and health. Publication activity also provides a basis for evaluating research development, collaboration, and dissemination across relevant academic communities.[1]

Research Impact

The supplied Scopus profile records 330 documents, 26,391 citations, and an h-index of 72, providing quantitative indicators of the visibility of the researcher’s indexed scholarly output. Such bibliometric measures offer useful context when assessing academic activity, although research impact is more comprehensively considered alongside publication quality, originality, collaboration, and substantive scientific contribution.[3]

Award Suitability

The documented academic profile is relevant to a Research Excellence Award because it demonstrates sustained scholarly activity across several interconnected biomedical disciplines. His research focus on nutrition, allergy, gastrointestinal health, microbiome-related science, and pediatric disease provides a multidisciplinary foundation for evaluation. The available publication and citation indicators further support consideration within an academic recognition framework.[4]

Conclusion

Roberto Berni Canani’s academic profile reflects sustained research activity in pediatric medicine, nutrition, gastroenterology, allergy, and related biomedical fields. His documented scholarly indicators and multidisciplinary research interests provide a substantial basis for academic evaluation. His work demonstrates the relevance of integrating clinical, nutritional, immunological, and translational perspectives in contemporary health research.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Roberto Berni Canani, Author ID 57008139600. Scopus.
    https://www.scopus.com/pages/authors/57008139600
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award Recognition. Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  4. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Berni Canani, R., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11, 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  5. Canani, R. B., Di Costanzo, M., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12), 1519–1528.
    https://doi.org/10.3748/wjg.v17.i12.1519